Skip to main content
Equibles

AGLY · Atlantis Glory Inc.

Track AGLY — free

Use AGLY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AGLY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.02 At close · Oct 31
Rebalance outlook locked
Going-concern doubt — flagged Oct 26, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about the Company’s ability to continue as a going concern.”
View the 10-Q filed Oct 26, 2026
Market Cap
$10.27M
Shares
603.97M
Volume · Oct 31 100 Avg daily vol (2 sessions) 1137

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.02 Open$0.02 Day$0.02–0.02 Available close range$0.02–10.00 Avg vol available · 17d305 Short int218 · 0.0% of shares · 3.6d Short vol45% DataJan 2020–Oct 2025 Filing10-Q · Oct 26

The closing range uses available history since Oct 17, 2025; less than a full year is stored.

Latest documents

2026
Oct 26
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3

Atlantis Glory Inc. reported no revenue and a $24,377 net loss for the nine months ended September 30, 2026. At September 30, 2026, it had $0 cash and a $1,170,784 accumulated deficit, raising doubt about continuing as a going concern.

Net loss $7575 Diluted EPS $0.00
Read from the MD&A section
Mar 6
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Net loss $39.2K Diluted EPS $0.00
2025
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$39,722
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
-2,610.4%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
—
Trailing year
Short interest
—
Latest settlement
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Limited Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 18.7 · elevated Equity put/call 0.72
Technical
price trend
Sell
50 / 200-day cross No cross
RSI (14) 46
neutral
52-week position 0%
near low
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of shares out · ▬ 0.0% MoM · 3.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Weak
Gross margin 25%
Free cash flow $-239.3K
Quant / Vol
risk profile
Very High
Volatility 1967%
annualized · 1-yr
Max drawdown −100%
past year
ATR 13533.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
1 · 2 · 0
50 / 200-day cross
No cross Neutral
RSI (14)
46 Neutral
52-week position
0% Bearish
Market signals — smart money & positioning
No clear signal
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of shares out · ▬ 0.0% MoM · 3.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its available closing range
Range low $0 Now $0 · 0% Range high $10

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AGLY
Atlantis Glory Inc.
this stock
$10.27M — +644.6% — 0.0%
VYLR
Vylor Inc.
 $48.09B — — — 2.1%
CLUS
Cluster Group Holdings Ltd Co
 $8.00B — — — —
DMII
Drugs Made In America Acquisition II Corp.
 $652.61M +3.5% — — 0.0%
EVAC
EQV Ventures Acquisition Corp. II
 $606.10M +3.4% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest
Shares short
218
Days to cover
3.6d
Change
0 sh
View
Short Volume
Short vol %
45%
As of
Oct 17, 2025
Short Total
View
Fails to Deliver
FTD shares
6
Value
$75
As of
Jun 27, 2019
View
Off-Exchange
Off-exchange %
100.0%
Week of
Oct 27, 2025
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$156.0K
Net income (FY)
$-39.2K
EPS diluted
$0.00
View
Filings
SEC Filings
Latest
10-Q
Filed
Oct 26, 2026
This year
4

Atlantis Glory Inc. reported no revenue and a $24,377 net loss for the nine months ended September 30, 2026. At September 30, 2026, it had $0 cash and a $1,170,784 accumulated deficit, raising doubt about continuing as a going concern.

View

Performance

5D 20D 120D MTD YTD
AGLY -99.4% — — -99.2% -99.2%
SPY +0.7% +1.9% +17.0% +2.4% +16.4%
vs SPY -100.1% — — -101.6% -115.6%
Key facts CIK 1673504